strontium has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| COSGROVE, GE; UPTON, AC | 1 |
| Abe, Y; Fujita, S; Ishida, Y; Kaneko, S; Kasahara, Y; Ohminami, H; Yakushijin, Y; Yasukawa, M | 1 |
2 other study(ies) available for strontium and Leukemia, Myeloid
| Article | Year |
|---|---|
Some late effects of radiostrontium in RF male mice.
Topics: Animals; Leukemia; Leukemia, Myeloid; Mice; Radiation Injuries, Experimental; Radioactivity; Strontium; Strontium Radioisotopes | 1962 |
Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide.
Topics: Acute Disease; Amino Acid Sequence; Anti-Bacterial Agents; Apoptosis; CD4-Positive T-Lymphocytes; Cytotoxicity, Immunologic; Fas Ligand Protein; fas Receptor; Gene Expression Regulation; Granzymes; Humans; Leukemia, Myeloid; Lymphokines; Lymphotoxin-alpha; Macrolides; Membrane Glycoproteins; Molecular Sequence Data; Oncogene Proteins; Oncogene Proteins, Fusion; Perforin; Pore Forming Cytotoxic Proteins; Recombinant Fusion Proteins; Serine Endopeptidases; Strontium; T-Lymphocytes, Cytotoxic; Tumor Necrosis Factor-alpha | 1999 |